维普中文期刊产品整合服务
88篇 您的检索式:作者名="Khadka"
    题名 作者 年代 出处 被引量
1Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability显示文摘Pharmaceutical particle technology is employed to improve poor aqueous solubility of drug compounds that limits in vivo bioavailability owing to their low dissolution rate in the gastrointestinal fluids following oral administration.The particle technology involves several approaches from the conventional size reduction processes to the newer,novel particle technologies that modify the solubility properties of the drugs and produce solid,powdered form of the drugs that are readily soluble in water and can be easily formulated into various dosage forms.This review highlights the solid particle technologies available for improving solubility,dissolution and bioavailability of drugs with poor aqueous solubility.Prakash Khadka Jieun Ro Hyeongmin Kim Iksoo Kim Jeong Tae Kim Hyunil Kim Jae Min Cho Gyiae Yun Jaehwi Lee 2014Asian Journal of Pharmaceutical Sciences2014,9,6:15
2Assessment of Hydrocarbon Prospectivity in Terai and Siwaliks, Exploration Block 2, Western Nepal显示文摘Dharma Raj Khadka 2017Journal of Geological Resource and Engineering2017,5,3:3
3Is laser photocoagulation still effective in diabetic macular edema? Assessment with optical coherence tomography in Nepal显示文摘AIM: To find out the outcome of laser photocoagulation in clinically significant macular edema (CSME) by optical coherence tomography (OCT). · METHODS: It was a prospective, non-controlled, case series study enrolling 81 eyes of 64 patients with CSME between August 2008 and January 2010. All patients received modified grid photocoagulation with frequency doubled Nd: YAG laser. Each patient was evaluated in terms of best-corrected visual acuity (BCVA) and regression or progression of maculopathy after laser therapy at 1, 3 and 6 months. Spearman's correlation test was used to show the correlation between BCVA and total macular volume (TMV). Analysis of variance (ANOVA) was used to compare among groups and independent t-test was used to compare in each group. · RESULTS: There is high correlation between BCVA and TMV (P ≤0.001). BCVA improved in 50.6%, remained static in 39.5 % and deteriorated in 9.9% patients after 6 month of treatment. The Baseline TMV (mean and SD) were 9.26±1.83, 10.4±2.38, 11.5±3.05, 8.89±0.75 and 9.47±1.98 mm3 for different OCT patterns, ST (sponge like thickening), CMO (cystoid macular edema), SFD (subfoveal detachment), VMIA (Vitreo macular interface abnormality) and average TMV respectively (P =0.04). After 6 months of laser treatment, the mean TMV decreased from 9.47±1.98mm3 to 8.77±1.31mm3(P =0.01). In ST there was significant decrease in TMV, P =0.01, Further within these groups at 6 months, they were significantly different, P =0.01. · CONCLUSION: OCT showed the different morphological variant of CSME while the response of treatment is different. TMV decreased the most and hence showed the improvement in vision after 6 months of laser treatment. In the era of Anti vascular endothelial growth factors (VEGFs), efficacy of laser seems to be in shadow but it is still first line of treatment in developing nation like Nepal where antiVEGFs may not be easily available and affordable.Arjun Shrestha Deepak Khadka Angira Karmacharya Nhukesh Maharjan Anand Shrestha Raba Thapa Govinda Poudyal 2012International Journal of Ophthalmology(English edition)2012,5,2:3
4Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems显示文摘The therapeutic potential of saquinavir, a specific inhibitor of human immunodeficiency virus(HIV)-1 and HIV-2 protease enzymes, has been largely limited because of a low solubility and consequnt low bioavailability. Thus, we aimed to design a supersaturated selfmicroemulsifying drug delivery system(S-SMEDDS) that can maintain a high concentration of saquinavir in gastro-intestinal fluid thorugh inhibiting the drug precipitation to enhance the lymphatic transport of saquinavir and to increase the bioavailability of saquinavir considerably. Solubilizing capacity of different oils, surfactants, and cosurfactants for saquinavir was evaluated to select optimal ingredients for preparation of SMEDDS.Through the construction of pseudo-ternary phase diagram, SMEDDS formulations were established. A polymer as a precipitation inhibitor was selected based on its viscosity and drug precipitation inhibiting capacity. The S-SMEDDS and SMEDDS designed were administered at an equal dose to rats. At predetermined time points, levels of saquinavir in lymph collected from the rats were assessed. SMEDDS prepared presented a proper selfmicroemulsification efficiency and dispersion stability. The S-SMEDDS fabricated using the SMEDDS and hydroxypropyl methyl cellulose 2910 as a precipitation inhibitor exhibited a signficantly enhanced solubilizing capacity for saquinavir. The drug concentration in a simulated intestinal fluid evaluated with the S-SMEDDS was also maintained at higher levels for prolonged time than that examined with the SMEDDS. The S-SMEDDS showed a considerably enhanced lymphatic absoprtion of saquinavir in rats compared to the SMEDDS.Therefore, the S-SMEDDS would be usefully exploited to enhance the lymphatic absorption of hydrophobic drugs that need to be targeted to the lymphatic system.Kanghee Jo Hyeongmin Kim Prakash Khadka Taejun Jang Soo Jin Kim Seong-Ha Hwang Jaehwi Lee 2020Asian Journal of Pharmaceutical Sciences2020,15,3:2
5Single burr hole for chronic subdural hematoma显示文摘Khadka NK Sharme GKR Roka YB 2008Nepal Med Coll J2008,10,:1
6Human RECQL1participates in telomere maintenance显示文摘Popuri V Hsu J Khadka P 2014Nucleic Acids Res2014,42,9:1
7Topoisomerase inhibitors as anticancer agents: a patent update显示文摘Daulat B Khadka Won-Jea Cho 2013Expert Opinion on Therapeutic Patents2013,,8:1
8CAD/CAM and rapid prototyped ti- tanium for reconstruction of ramus defect and condylar fracture caused by mandibular reduction 显示文摘WangG Li J Khadka A 2012Oral Surg Oral Med Oral Pathol Oral Radi2012,113,3:1
9Cardiovascular autonomic function and vibration perception threshold in type 2 diabetes mellitus 显示文摘Goit RK Khadka R Sharma SK 2012J Diabetes Complications2012,26,4:1
10Effectiveness of the community- based Low Vision Service Wales: a long-term outcome study显示文摘Ryan B Khadka J Bunce C 2013Br J Ophthalmo12013,97,4:1
11Control of multitransparency windows via dark-state phase manipulation显示文摘U Khadka Y P Zhang M Xiao 2010Phys Rev A2010,81,02:1
12Denosumab: A bone antiresorptive drug显示文摘Navdeep Dahiya Anjan Khadka A.K. Sharma A.K. Gupta Nishith Singh D.B.S. Brashier 2014Medical Journal Armed Forces India2014,,:1
13Etiology of urinary tract infection and drug resistance cases of uropathogenes显示文摘Bhatt CP Shrestha B Khadka S 2013J Kathmandu Med Coll2013,1,2:1
14Cognitive trajectories after postoperative delirium显示文摘KHADKA J MCALINDEN C PESUDOVS K 2012N Engl J Med2012,367,12:1
15DNA markers for sex: Molecular evidence for gender dimorphism in dioecious Mercurialis annua L.显示文摘D.K. Khadka A. Nejidat M. Tal A. Golan-Goldhirsh 2002Molecular Breeding2002,,4:1
16Low-cost struviteproduction using source - separated urine in Nepal 显示文摘Etter B Tilley E Khadka R Water R es0,45,2:1
17Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors 显示文摘YANG S H KHADKA D B CHO S H 2011Bioorg Med Chem2011,19,12:1
18CAD/CAM and rapid prototyped titanium for reconstruction of ramus defect and condylar fracture-caused by mandibular reduction 显示文摘Wang G Li J Khadka A 2012Oral Surg Oral Med Oral Pathol Oral Radiol2012,113,3:1
19A comprehensive evalua- tion of the precision(repeatability and reproducibility)of the Oc- ulus Pentacam HR显示文摘McAlinden C Khadka J Pesudovs K 2011Invest Ophthalmol Vis Sci2011,52,:1
20Oxidative DNA damage and inflammatory responses in cultured human cells and in humans exposed to traffic-related particles 显示文摘Vattanasit U Navasumrit P Khadka MB 2014Int J Hyg Environ Health2014,217,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费